Synergistic Fluid Transfer System in Robotic Pharmaceutical Preparation

Publication ID: 24-11857497_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Fluid Transfer System in Robotic Pharmaceutical Preparation,” Published Technical Disclosure No. 24-11857497_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857497_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,497.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and nanomaterials to enhance fluid transfer efficiency, security, and monitoring in robotic pharmaceutical preparation systems.

Background and Problem Solved

The original patent for fluid transfer stations in robotic pharmaceutical preparation systems has limitations in terms of real-time monitoring, security, and efficiency. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The synergistic fluid transfer system comprises a fluid transfer station integrated with an AI-powered monitoring module for real-time tracking and optimization of fluid transfer operations. Additionally, the system utilizes a blockchain-based authentication protocol to verify the identity of fluid transfer components and ensure secure data exchange. An IoT-enabled sensor network monitors and controls environmental conditions affecting fluid transfer operations. The fluid transfer assembly features a novel nanomaterial-based coating for reducing friction and improving fluid transfer efficiency. The system also integrates a computer vision module with machine learning algorithms for detecting and responding to fluid transfer anomalies.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and nanomaterials, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these technologies to create a more efficient, secure, and monitored fluid transfer system.

Alternative Embodiments and Variations

Alternative embodiments could include the use of different AI algorithms, varying IoT sensor configurations, or alternative blockchain protocols. The inventive concept could also be adapted for use in other industries, such as biotechnology or medical research.

Potential Commercial Applications and Market

The synergistic fluid transfer system has significant commercial potential in the pharmaceutical industry, particularly in hospitals and clinical settings. The system's enhanced efficiency, security, and monitoring capabilities make it an attractive solution for pharmaceutical companies and healthcare providers.

CPC Classifications

SectionClassGroup
A A61 A61J1/2055
A A61 A61J1/1406
B B25 B25J13/08
B B65 B65B3/003
A A61 A61J2200/70

Field of Art

Robotic pharmaceutical preparation systems, specifically fluid transfer technologies involving precision manipulation, sensor integration, and automated component interaction in medical device engineering

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or robotics specialist with expertise in medical automation, having advanced knowledge of robotic manipulation, sensor technologies, and pharmaceutical handling protocols, typically holding a Master's or PhD in biomedical engineering or related field

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies into existing robotic pharmaceutical transfer systems represents a predictable technological evolution. The source patent's fundamental fluid transfer mechanism provides a clear technological foundation that naturally invites enhancement through contemporary digital monitoring and authentication technologies. The proposed variations represent incremental improvements using well-established technological approaches in medical automation and robotics.

Obvious Combinations & Variations

Source Patent Element
Robotic manipulator with precise septum contact and fluid transfer capabilities
PTD Variation
Adding computer vision and machine learning for anomaly detection during fluid transfer
Obviousness Reasoning
Integrating machine learning for error detection is a known technique in robotic systems, representing a predictable application of contemporary AI technologies to existing robotic platforms
Source Patent Element
Fluid transfer station with mechanical precision controls
PTD Variation
Implementing IoT sensor network for environmental condition monitoring
Obviousness Reasoning
Extending mechanical systems with sensor-based monitoring is a standard approach in advanced robotics, providing enhanced operational intelligence through readily available technological components
Source Patent Element
Robotic system for pharmaceutical fluid handling
PTD Variation
Blockchain-based authentication protocol for component verification
Obviousness Reasoning
Applying blockchain authentication to existing technological systems represents a logical security enhancement using established cryptographic techniques
Source Patent Element
Fluid transfer mechanism with septum contact
PTD Variation
Nanomaterial-based coating for reducing friction in transfer operations
Obviousness Reasoning
Surface modification using advanced materials is a predictable optimization strategy in precision mechanical systems, representing a routine engineering design choice
Source Patent Element
Robotic pharmaceutical preparation system
PTD Variation
AI-powered monitoring module for real-time tracking and optimization
Obviousness Reasoning
Implementing AI-driven monitoring represents a standard technological progression in automated systems, utilizing known machine learning techniques to enhance operational intelligence
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857497 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed fluid transfer system enhancements obvious and predictable. The combination of existing robotic pharmaceutical transfer mechanisms with contemporary digital technologies represents an incremental and foreseeable technological development that does not rise to the level of non-obvious invention.

Original Patent Information

Patent NumberUS 11,857,497
TitleFluid transfer station in a robotic pharmaceutical preparation system
Assignee(s)EQUASHIELD MEDICAL LTD